SNG.L
Price:
$4.5
Market Cap:
$9.06M
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease. The company has a licensing and collaboration agreement with Pharmaxis Ltd. to develop a LOXL2 inhibitor. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.[Read more]
Industry
Biotechnology
IPO Date
2004-10-26
Stock Exchange
LSE
Ticker
SNG.L
According to Synairgen plc’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Synairgen plc over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), SNG.L's Dividend Yield was at its highest in in the June 2008 quarter at 0%. The Dividend Yield was at its lowest in in the June 2008 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Synairgen plc Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2023 | 0% | 0% |
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
2019 | 0% | 0% |
2018 | 0% | 0% |
2017 | 0% | 0% |
2016 | 0% | 0% |
2015 | 0% | 0% |
2014 | 0% | 0% |
The current Dividend Yield of Synairgen plc (SNG.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Synairgen plc’s Dividend Yield is less than Omega Diagnostics Group PLC (0%), less than Avacta Group Plc (0%), less than Novacyt S.A. (0%), less than genedrive plc (0%), less than Greatland Gold plc (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $4.94M | |
0% | $190.99M | |
0% | $39.27M | |
0% | $12.66M | |
0% | $645.43M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Synairgen plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Synairgen plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Synairgen plc's Dividend Yield?
How is the Dividend Yield calculated for Synairgen plc (SNG.L)?
What is the highest Dividend Yield for Synairgen plc (SNG.L)?
What is the 3-year average Dividend Yield for Synairgen plc (SNG.L)?
What is the 5-year average Dividend Yield for Synairgen plc (SNG.L)?
How does the current Dividend Yield for Synairgen plc (SNG.L) compare to its historical average?